NO20014976D0 - Dibenzoazulenderivater for behandling av trombose, osteoporose og arteriosklerose - Google Patents
Dibenzoazulenderivater for behandling av trombose, osteoporose og arterioskleroseInfo
- Publication number
- NO20014976D0 NO20014976D0 NO20014976A NO20014976A NO20014976D0 NO 20014976 D0 NO20014976 D0 NO 20014976D0 NO 20014976 A NO20014976 A NO 20014976A NO 20014976 A NO20014976 A NO 20014976A NO 20014976 D0 NO20014976 D0 NO 20014976D0
- Authority
- NO
- Norway
- Prior art keywords
- dibenzoazulin
- arteriosclerosis
- thrombosis
- osteoporosis
- derivatives
- Prior art date
Links
- 206010003210 Arteriosclerosis Diseases 0.000 title 1
- 208000001132 Osteoporosis Diseases 0.000 title 1
- 208000007536 Thrombosis Diseases 0.000 title 1
- 208000011775 arteriosclerosis disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19916837A DE19916837A1 (de) | 1999-04-14 | 1999-04-14 | Dibenzoazulenderivate |
| PCT/EP2000/002925 WO2000063178A1 (de) | 1999-04-14 | 2000-04-01 | Dibenzoazulenderivate zur behandlung von thrombose, osteoporose, arteriosklerose |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20014976L NO20014976L (no) | 2001-10-12 |
| NO20014976D0 true NO20014976D0 (no) | 2001-10-12 |
Family
ID=7904536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20014976A NO20014976D0 (no) | 1999-04-14 | 2001-10-12 | Dibenzoazulenderivater for behandling av trombose, osteoporose og arteriosklerose |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6521646B1 (no) |
| EP (1) | EP1169306A1 (no) |
| JP (1) | JP2002542231A (no) |
| KR (1) | KR20010102570A (no) |
| CN (1) | CN1345312A (no) |
| AR (1) | AR023496A1 (no) |
| AU (1) | AU3817400A (no) |
| BR (1) | BR0009690A (no) |
| CA (1) | CA2367359A1 (no) |
| CZ (1) | CZ20013704A3 (no) |
| DE (1) | DE19916837A1 (no) |
| HU (1) | HUP0200643A3 (no) |
| MX (1) | MXPA01010294A (no) |
| NO (1) | NO20014976D0 (no) |
| PL (1) | PL350354A1 (no) |
| RU (1) | RU2001129708A (no) |
| SK (1) | SK14342001A3 (no) |
| WO (1) | WO2000063178A1 (no) |
| ZA (1) | ZA200109343B (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2806082B1 (fr) * | 2000-03-07 | 2002-05-17 | Adir | Nouveaux composes bicycliques antagonistes des recepteurs de la vitronectine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US6613921B2 (en) | 2000-06-30 | 2003-09-02 | Dow Global Technologies Inc. | Polycyclic, fused ring compounds, metal complexes and polymerization process |
| US20050107350A1 (en) * | 2003-08-22 | 2005-05-19 | Pharmacia Corporation | Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith |
| JP4943324B2 (ja) | 2004-06-04 | 2012-05-30 | ザ スクリプス リサーチ インスティチュート | 新生血管病の治療のための組成物および方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3795709A (en) * | 1968-02-07 | 1974-03-05 | Sandoz Ag | Benzobenzazulenes |
| EP0820426B1 (en) * | 1995-03-09 | 2000-06-14 | Ortho Pharmaceutical Corporation | SUBSTITUTED DIBENZ[a,f]AZULENES AND METHODS OF PREPARATION |
| PT910563E (pt) * | 1995-06-29 | 2003-09-30 | Smithkline Beecham Corp | Antagonistas de receptores de integrina |
| EP0888292B1 (fr) * | 1996-03-20 | 2001-10-31 | Aventis Pharma S.A. | COMPOSES TRICYCLIQUES AYANT UNE ACTIVITE VIS-A-VIS DES INTEGRINES NOTAMMENT VIS-A-VIS DE L'INTEGRINE ALPHA vBETA3, LEUR PROCEDE DE PREPARATION ET LES INTERMEDIAIRES DE CE PROCEDE, LEUR APPLICATION A TITRE DE MEDICAMENTS ET LES COMPOSITIONS PHARMACEUTIQUES LES RENFERMANT |
| CO4920232A1 (es) * | 1997-01-08 | 2000-05-29 | Smithkline Beecham Corp | Acidos aceticos dibenzo [a,d] cicloheptano con actividad antagonista del receptor de vitronectin |
-
1999
- 1999-04-14 DE DE19916837A patent/DE19916837A1/de not_active Withdrawn
-
2000
- 2000-04-01 AU AU38174/00A patent/AU3817400A/en not_active Abandoned
- 2000-04-01 US US09/958,812 patent/US6521646B1/en not_active Expired - Fee Related
- 2000-04-01 KR KR1020017011575A patent/KR20010102570A/ko not_active Withdrawn
- 2000-04-01 PL PL00350354A patent/PL350354A1/xx unknown
- 2000-04-01 CA CA002367359A patent/CA2367359A1/en not_active Abandoned
- 2000-04-01 BR BR0009690-3A patent/BR0009690A/pt not_active Application Discontinuation
- 2000-04-01 WO PCT/EP2000/002925 patent/WO2000063178A1/de not_active Ceased
- 2000-04-01 SK SK1434-2001A patent/SK14342001A3/sk unknown
- 2000-04-01 EP EP00917037A patent/EP1169306A1/de not_active Withdrawn
- 2000-04-01 CZ CZ20013704A patent/CZ20013704A3/cs unknown
- 2000-04-01 HU HU0200643A patent/HUP0200643A3/hu unknown
- 2000-04-01 JP JP2000612271A patent/JP2002542231A/ja active Pending
- 2000-04-01 RU RU2001129708/04A patent/RU2001129708A/ru unknown
- 2000-04-01 MX MXPA01010294A patent/MXPA01010294A/es unknown
- 2000-04-01 CN CN00805748A patent/CN1345312A/zh active Pending
- 2000-04-14 AR ARP000101738A patent/AR023496A1/es unknown
-
2001
- 2001-10-12 NO NO20014976A patent/NO20014976D0/no not_active Application Discontinuation
- 2001-11-13 ZA ZA200109343A patent/ZA200109343B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010102570A (ko) | 2001-11-15 |
| CN1345312A (zh) | 2002-04-17 |
| RU2001129708A (ru) | 2004-02-27 |
| AR023496A1 (es) | 2002-09-04 |
| JP2002542231A (ja) | 2002-12-10 |
| BR0009690A (pt) | 2002-01-08 |
| EP1169306A1 (de) | 2002-01-09 |
| AU3817400A (en) | 2000-11-02 |
| PL350354A1 (en) | 2002-12-02 |
| NO20014976L (no) | 2001-10-12 |
| CZ20013704A3 (cs) | 2002-02-13 |
| WO2000063178A1 (de) | 2000-10-26 |
| MXPA01010294A (es) | 2002-05-06 |
| DE19916837A1 (de) | 2000-10-19 |
| HUP0200643A2 (hu) | 2002-07-29 |
| US6521646B1 (en) | 2003-02-18 |
| ZA200109343B (en) | 2003-04-30 |
| CA2367359A1 (en) | 2000-10-26 |
| SK14342001A3 (sk) | 2002-04-04 |
| HUP0200643A3 (en) | 2003-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20013380L (no) | 2-aminobenzoksazinonderivater for behandling av fedme | |
| NO20014379D0 (no) | Anvendelse av Xenon for behandling av Neurointoksikasjoner | |
| NO20013381D0 (no) | 2-oksybenzoksazinonderivater for behandling av fedme | |
| NO20013369D0 (no) | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon | |
| FI20000863A0 (fi) | Uusi hoitomenetelmä | |
| NO20015156D0 (no) | 5-pyridyl-1,3-Azol forbindelser, fremgangsmåte for produksjon av de samme og deres anvendelse | |
| NO20015542D0 (no) | Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner | |
| NO20022087D0 (no) | Fremgangsmåte for behandling av diabetes | |
| DE50006919D1 (de) | Femurschlitten | |
| NO20012963D0 (no) | Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler | |
| NO20033498D0 (no) | Fremgangsmåte for behandling og törking av trevirke | |
| DK1202996T3 (da) | Titanforbindelser, fremstilling og anvendelse heraf | |
| NO20015772L (no) | Forbindelser og fremgangsmåter for behandling av post- traumatisk stress-syndrom | |
| DK1041985T3 (da) | Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme | |
| NO20001909L (no) | FremgangsmÕte og anlegg for fremstilling av 1,2-dikloretan | |
| NO20010456D0 (no) | Triazolopyridiner for behandling av trombose-problemer | |
| NO20001758D0 (no) | Fremgangsmåter og blandinger for behandling av leddgikt | |
| NO20014976D0 (no) | Dibenzoazulenderivater for behandling av trombose, osteoporose og arteriosklerose | |
| NO20012099D0 (no) | Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser | |
| NO20022990D0 (no) | Fremgangsmåte og sammensetning for behandling av smerte | |
| NO20022482D0 (no) | 2-arylkinolinderivater, fremgangsmåte og terapeutisk anvendelse derav | |
| NO20014476L (no) | Behandling av hiatial hernia | |
| DK1043026T3 (da) | Melanombehandling | |
| NO995314D0 (no) | For og anvendelse av slikt for | |
| SE9903421D0 (sv) | Behandlingsförfarande |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |